Scott P. Kelly, PhD

Senior Director, Global Medical Epidemiology
Pfizer Inc

Scott Kelly is a Senior Director of Epidemiology at Pfizer, focusing on vaccine (COVID mRNA, RSV, Lyme, Pneumococcal, C-Diff) and hospital (antimicrobial resistance, anti-bacterial, anti-fungal and anti-viral (RSV and COVID)) epidemiology.

Poster(s):

• (287) A Replication of the Incidence Rate Estimates of Selected Adverse Events of Special Interest (AESIs) from the vACCine covid-19 monitoring readinESS (ACCESS) in the EU with US Real World Data
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (AM) Natural History of Wilson's Disease in the United States Using Optum® Electronic Health Records
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (23) Prevalence and Clinical Burden of Genetic Dilated Cardiomyopathy in The United States: Results from The Optum® Electronic Health Records Database
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST